Fada Pharma fadapharma.com.ar


Public lists: Pharma Startups (4732)

Fada Pharma is Argentina's leading manufacturer of generic pharmaceuticals for the institutional market

Fada Pharma is Argentina's leading manufacturer of generic pharmaceuticals for the institutional market

Company (Alive / Active)

Phone: (54-11) 5217-3200

Fax:

Tronador 4890 - piso 11
(C1430DNN)
Argentina

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Fada Pharma $0M Nov 13, 2018
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Fada Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

RxKinetix

Boulder, Colorado, United States
AcquiredRxKinetix is a product-focused specialty pharmaceutical company engaged in the research and development of novel pharmaceutical formulations. The company's lead product is RK-0202, an oral rinse for the prevention and treatment of oral mucositis, a painful and debilitating side-effect of cancer therapy. RxKinetix also has an emerging anti-viral formulation for the prevention and treatment of herpes simplex outbreaks, as well as programs involving vaccine, therapeutic antibody, and growth factor ...Show allLogin to see details

Nycomed

Zurich, Switzerland
AcquiredNycomed is a global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has...Show allLogin to see details
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)